Navigation Links
14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
Date:2/10/2009

The 2009 Wharton Health Care Business Conference, an MBA-student organized event, will be held February 19-20 in Philadelphia. The dynamic two-day event will feature distinguished speakers and panelists from Healthcare Services, Investment, Pharma, Biotech, and Medical Device sectors.

Philadelphia, PA (PRWEB) February 10, 2009 -- The 2009 Wharton Health Care Business Conference, an MBA-student organized event, will be held February 19-20 at the Park Hyatt Hotel at The Bellevue in Philadelphia, PA. Distinguished speakers and panelists from across the health care industry include:


  • Wayne Gattinella - President, CEO, Director, WebMD
  • John Hammergren - Chairman, President, CEO, McKesson
  • Michael McCallister - President, CEO, Humana
  • Israel Makov - Chairman, Given Imaging, Former CEO, Teva Pharmaceuticals
  • Kent Thiry - Chairman, CEO, DaVita
  • Ronald Paulus - Executive Vice President, CTO, CIO, Geisinger Health System

Discussion Panel Sessions offered include:
  • The Blurring Line Between Pharma and Biotech - Featuring panelists from Wyeth, Pfizer, Amgen, Bank of America Merrill Lynch Securities, Orbimed, and Booz & Co.
  • Overcoming Hurdles: Financing Growth In A Capital Constrained World - Featuring panelists from JP Morgan, Aisling Capital, Johnson & Johnson Development Corporation, Cain Brothers & Co., and Deloitte Consulting
  • Policy: Will Reform Become Reality? - Featuring panelists from Independence Blue Cross, Putnam Associates, American Medica
    '/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
2. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
3. Sunesis to Present at the 11th Annual BIO CEO & Investor Conference
4. Alexzas Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
5. Advanced Life Sciences to Present at the 11th Annual BIO CEO & Investor Conference
6. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
7. MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference
8. Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference
9. Complete Genomics to Release Its DNA Sequencing Data for the First Time at Advances in Genome Biology and Technology Annual Meeting
10. Indevus Pharmaceuticals Announces Release of 2008 Annual Report
11. Cell Therapeutics, Inc. (CTI) to Present at 11th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
(Date:8/4/2015)... LOS ANGELES , Aug. 4, 2015   ... announced the recent acquisition of LifeLine Cryogenics, an east ... the New York tristate area. ... tissues, and all prepaid contracts will be honored. ... of cryogenics services, offering storage of sperm, eggs, embryos, ...
(Date:8/3/2015)... , Aug. 3, 2015  MiMedx Group, Inc. ... utilizing human amniotic tissue and patent-protected processes to develop ... Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental ... at the 35 th Annual Canaccord|Genuity Growth Conference ... "Pete" Petit, Chairman and CEO, William C. Taylor ...
(Date:8/3/2015)... , August 3, 2015 ... the commercialization of its Bio-electrical Signal Therapy device ("BST ... treatment of hard to heal chronic wounds, today announced ... with Chemipal, an Israeli distributor specializing in medical devices, ... Chemipal is a 70 years old, sales, ...
(Date:7/31/2015)... In today,s fast changing healthcare environment, ... positive health outcomes, improve profitability and enhance their ... in their communities. At ThoughtSpot 2015, Good ... announced a new set of innovative capabilities that ... help independent pharmacies endure the industry,s most pressing ...
Breaking Biology Technology:FamilyCord Announces Acquisition of LifeLine Cryogenics 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3
... Osteotech, Inc. (Nasdaq: OSTE ), a leader ... today that the Company,s second quarter ended June 30, 2010 ... Monday, August 9, 2010 .  The management team of Osteotech ... 9, 2010 , at 9:00 a.m. (EDT) to discuss ...
... Mass. , Aug. 4 New England ... Michael Smith Genome Sciences Center has selected New England ... sequencing library construction reagents. NEBNext DNA Sample Prep Reagent ... and validated for sample preparation for next generation sequencing, ...
... Elusys Therapeutics, Inc. (Elusys), a privately-held ... second contract year of funding valued at $40.6 million ... and treatment of anthrax infection following a biowarfare attack. This ... received under this contract and is part of a potential ...
Cached Biology Technology:Osteotech Announces Second Quarter 2010 Financial Results Release and Conference Call 2Canada's Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing 2Canada's Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing 3Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax 2Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax 3
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
(Date:7/31/2015)... 31 de julho de 2015 A 10 ... ) será realizada pela BGI de 22-25 de outubro de ... A conferência está celebrando seu 10 o. ... ICG se tornou uma das reuniões mais influentes do ... científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 /PRNewswire/ ... www.icg-10.org ) se celebrará por medio de BGI del 22 ... China . Este año, la conferencia ... 2006, ICG se ha convertido en una de las reuniones ... de ser una de las reuniones más dinámicas, entusiastas y ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... Vermillion, Inc. (NASDAQ: VRML ), a ... health, announced the signing of a cooperative research and development ... Materiel Command (USAMRMC). The agreement kicks off ... Treatment Algorithm for Adnexal Masses in Women," and follows ...
... is pleased to announce it has received a grant ... Advanced Life Sciences Training Program. The grant will ... July 2013 for all five classes of participants in ... 2008. The Fellows Program is a high-level life science ...
... KISS 1 is a metastasis-suppressor gene which helps to ... ovarian cancers to name a few. But new ... Dentistry shows that kisspeptins peptide products of KISS1, actually ... grade and metastatic potential. The research is published ...
Cached Biology News:U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 2U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 3U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 4Keystone Symposia announces grant from Alfred P. Sloan Foundation 2
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
... separation and fractionation of nucleic-acid ... nuclei from cytosolic proteins A ... greatly facilitating study of low-abundance ... acid binding proteins (e.g., transcription ...
... whose sequence corresponds to residues 1-18 from rat rab 3D. ... - A - S - A - S - E - ... - D - A - A - D - Q - ... control experiments with the polyclonal antibody that reacts with this product ...
... or individual RNA sequences from high throughput synthesis ... RNAs from LC Sciences. These products provide a ... of DESIGNED sequences delivered in a microtube as ... a single verified RNA sequence. This is a ...
Biology Products: